References
- European Monitoring Centre for Drugs and Drug Addiction. Perspectives on drugs, synthetic cannabinoids in Europe. Luxembourg: Publications Office of the European Union; 2017.
- European Monitoring Centre for Drugs and Drug Addiction. European drug report 2018: trends and developments. Luxembourg: Publications Office of the European Union; 2018.
- United Nations Office on Drugs and Crime. World drug report 2018. United Nations publication; 2018.
- EMCDDA. European Database on New Drugs (EDND). https://ednd.emcdda.europa.eu/ [Accessed 10 December 2018].
- World Health Organization, Critical Review Report: FUB-AMB (MMB-FUBINACA, AMB-FUBINACA), Expert Committee on Drug Dependence Forty-first Meeting, Geneva, 12 Nov–16 Nov 2018. http://www.who.int/medicines/access/controlled-substances/Fub_amb.pdf
- Adams AJ, Banister SD, Irizarry L, et al. "Zombie" outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York. N Engl J Med. 2017;376:235–242.
- https://www.reddit.com/r/researchchemicals/comments/5xcw82/fubamb_ambfubinaca_report/ [Accessed 10 December 2018].
- https://hyperreal.info/talk/fub-amb-t44546.html [Accessed 10 December 2018].
- https://forum.dopalamy.com/topic/10829-fub-amb-amb-fubinaca/ [Accessed 10 December 2018].
- Doi T, Tagami T, Takeda A, et al. Evaluation of carboxamide-type synthetic cannabinoids as CB1/CB2 receptor agonists: difference between the enantiomers. Forensic Toxicol. 2018;36:51–60.
- Adamowicz P, Tokarczyk B. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry. Drug Test Analysis. 2016;8:652–667.
- Ambroziak K, Adamowicz P. Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography–tandem mass spectrometry. Forensic Toxicol. 2018;36:280–290.
- Seely KA, Lapoint J, Moran JH, et al. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:234–243.
- https://www.reddit.com/r/researchchemicals/comments/4dre6j/a_look_so_far_into_my_use_of_fubamb/. [Accessed 10 December 2018].
- Hamilton RJ, Keyfes V, Banka SS. Synthetic cannabinoid abuse resulting in ST-segment elevation myocardial infarction requiring percutaneous coronary intervention. J Emerg Med. 2017;52:496–498.
- Thornton SL, Bram D, Milligan D, et al. Rhabdomyolysis associated with laboratory confirmed FUB-AMB use. Clin Toxicol. 2015;53:650–651.
- https://www.nytimes.com/2016/12/14/nyregion/zombielike-state-was-caused-by-synthetic-marijuana.html [Accessed 10 December 2018].
- Kappatos D, Johnson C, Ong R, et al. ‘Border to Grave’ surveillance of new psychoactive substances in New Zealand: The dramatic impact of AMB-FUBINACA. Flash presentation at 56th TIAFT Annual Meeting, Ghent (Belgium), 26 Aug–30 Aug, 2018.
- Gamage TF, Farquhar CE, Lefever TW, et al. Molecular and behavioral pharmacological characterization of abused synthetic cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. J Pharmacol Exp Ther. 2018;365:437–446.
- Presley BC, Gurney SM, Scott KS, et al. Metabolism and toxicological analysis of synthetic cannabinoids in biological fluids and tissues. Forensic Sci Rev. 2016;28:103–169.
- Abbate V, Schwenk M, Presley BC, et al. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl Chem. 2018;90:1255–1282.
- https://sin.org.pl/uwaga-bakus-vip/ [Accessed 10 December 2018]
- Zgair A, Lee JB, Wong JCM, et al. Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation. Sci Rep. 2017;7:14542.
- Hasegawa K, Wurita A, Minakata K, et al. Identification and quantitation of 5-fluoro-ADB, one of the most dangerous synthetic cannabinoids, in the stomach contents and solid tissues of a human cadaver and in some herbal products. Forensic Toxicol. 2015;33:112–121.
- Cooper ZD. Adverse effects of synthetic cannabinoids: management of acute toxicity and withdrawal. Curr Psychiatry Rep. 2016;18:52.
- Bick BL, Szostek JH, Mangan TF. Synthetic cannabinoid leading to cannabinoid hyperemesis syndrome. Mayo Clin Proc. 2014;89:1168–1169.
- Erol Öztürk Y, Yeter O, Alpertunga B. Validation of JWH-018 and its metabolites in blood and urine by UPLC-MS/MS: monitoring in forensic cases. Forensic Sci Int. 2015;248:88–93.
- Znaleziona J, Ginterová P, Petr J, et al. Determination and identification of synthetic cannabinoids and their metabolites in different matrices by modern analytical techniques - a review. Anal Chim Acta. 2015;874:11–25.
- Molina DK. Handbook of forensic toxicology for medical examiners. Boca Raton (FL): CRC Press; 2010.